It was recently reported that Oct1 may protect hematopoietic stem and progenitor cells (HSPCs) from proliferative stress and was required for AML development mediated by the fusion oncoprotein MLL-AF9 [9, 11]. The gene discussed is KMT2A; the disease is acute myeloid leukemia.